This page is part of the FHIR Specification (v1.1.0: STU 3 Ballot 1). The current version which supercedes this version is 5.0.0. For a full list of available versions, see the Directory of published versions . Page versions: R5 R4B R4 R3 R2
This is a frozen snapshot of the FHIR specification created for the purpose of balloting the GAO implementation Guide. It includes draft changes that may be part of the future DSTU 2.1 release but further change is expected. Readers should focus solely on the GAO implementation content, and FHIR DSTU 2 for other purposes.
Extensions: | |
openEHR-test | Observations that confirm or refute : Observations that confirm or refute the risk and/or the substance. |
openEHR-location | Body site of manifestations : The anatomical location / body site(s) where the symptoms manifested. |
openEHR-exposureDate | Date(/time) of first exposure to Substance : Record of the date and/or time of the first exposure to the Substance for this Reaction Event. |
openEHR-exposureDuration | Amount of time individual was exposed to Substance : The amount of time the individual was exposed to the Substance. |
openEHR-exposureDescription | Text description about exposure to the Substance : Text description about exposure to the Substance. |
openEHR-administration | Actual medication record, if known : Link to an actual medication administration record with the full details of the administration, if a link is known. |
openEHR-management | Clinical Management Description : Text description about the clinical management provided. |
openEHR-careplan | Clinical Management Details : Additional details about the clinical management provided for this Reaction Event. |